Surface protein profiling and subtyping of extracellular vesicles in body fluids reveals non‐CSF biomarkers of Alzheimer's disease
Journal of Extracellular Vesicles · 2024-04 · 13 (4)
DOI: 10.1002/jev2.12432 ↗At a glance
Journal article in Journal of Extracellular Vesicles, published online on 2024-04-11. Written by You Cai and 10 co-authors. Institution: Department of Geriatrics, Shenzhen Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People'…. Major MEDLINE topics: Alzheimer Disease, Extracellular Vesicles, Body Fluids. Cited 34 times so far (Crossref); 74 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: National Natural Science Foundation of China, Science, Technology and Innovation Commission of Shenzhen Municipality.
Topics: Demenz
Abstract (original language)
Noninvasive and effortless diagnosis of Alzheimer's disease (AD) remains challenging. Here we report the multiplexed profiling of extracellular vesicle (EV) surface proteins at the single EV level in five types of easily accessible body fluids using a proximity barcoding assay (PBA). A total of 183 surface proteins were detected on the EVs from body fluids collected from APP/PS1 transgenic mice and patients with AD. The AD‐associated differentially expressed EV proteins could discriminate between the control and AD/AD model samples with high accuracy. Based on machine learning predictive models, urinary EV proteins exhibited the highest diagnostic potential compared to those on other biofluid EVs, both in mice and humans. Single EV analysis further revealed AD‐associated EV subpopulations in the tested body fluids, and a urinary EV subpopulation with the signature proteins PLAU, ITGAX and ANXA1 could diagnose patients with AD in blinded datasets with 88% accuracy. Our results suggest that EVs and their subpopulations from noninvasive body fluids, particularly urine, are potential diagnostic biomarkers for AD.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Geriatrics, Shenzhen Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, China.
- Shenzhen Key Laboratory for Systemic Aging and Intervention, Health Science Center, Shenzhen University, Shenzhen, China.
- Department of Neurology, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, China.
- Guangdong Provincial Key Laboratory of Systems Biology and Synthetic Biology for Urogenital Tumors, Shenzhen Key Laboratory of Genitourinary Tumor, Department of Urology, The First Affiliated Hospital of Shenzhen Univer…
- Department of Biochemistry and Molecular Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Lead contact.
ORCID profiles: Yizhe Tang
Funding
- National Natural Science Foundation of China
- Science, Technology and Innovation Commission of Shenzhen Municipality
Cite
APA
Cai, Y., Chen, T., Cai, Y., Liu, J., Yu, B., Fan, Y., Su, J., Zeng, Y., Xiao, X., Ren, L., & Tang, Y. (2024). Surface protein profiling and subtyping of extracellular vesicles in body fluids reveals non‐CSF biomarkers of Alzheimer's disease. Journal of Extracellular Vesicles, 13(4). https://doi.org/10.1002/jev2.12432
Vancouver
Cai Y, Chen T, Cai Y, Liu J, Yu B, Fan Y, et al. Surface protein profiling and subtyping of extracellular vesicles in body fluids reveals non‐CSF biomarkers of Alzheimer's disease. Journal of Extracellular Vesicles. 2024;13(4). doi:10.1002/jev2.12432
BibTeX
@article{Cai2024,
author = {Cai, You and Chen, Ting and Cai, Yanling and Liu, Jiabang and Yu, Bin and Fan, Yixian and Su, Jun and Zeng, Yixuan and Xiao, Xiaohua and Ren, Lijie and Tang, Yizhe},
title = {Surface protein profiling and subtyping of extracellular vesicles in body fluids reveals non‐CSF biomarkers of Alzheimer's disease},
journal = {Journal of Extracellular Vesicles},
year = {2024},
volume = {13},
number = {4},
doi = {10.1002/jev2.12432}
}
EUVIMED